SCHEMBL8557237

SCHEMBL8557237

Cc1cnc(NC(=O)c2cc[c]cc2)s1

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.71
RAB9A P51151 14/20 0.62
NPC1 O15118 13/20 0.62
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
POLB P06746 1/20 0.62
PKM P14618 3/20 0.57
LMNA P02545 1/20 0.57
PAX8 Q06710 1/20 0.55
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 2/20 0.49
MAPK1 P28482 1/20 0.49
MAPT P10636 1/20 0.49
CASP3 P42574 1/20 0.49
SENP8 Q96LD8 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
AHR P35869 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1270133 0.84 SMN1; SMN2 (0.75) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL233270 0.84 SMN1; SMN2 (0.75) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL2629279 0.83 SMN1; SMN2 (1.00) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL8125122 0.83 SMN1; SMN2 (0.60) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL4290502 0.82 SMN1; SMN2 (0.71) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL10253092 0.82 SMN1; SMN2 (0.71) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL16594526 0.82 SMN1; SMN2 (0.71) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL6189521 0.81 CDK2 (0.75) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL16594522 0.79 SMN1; SMN2 (0.68) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL16607118 0.79 SMN1; SMN2 (0.68) SMN1; SMN2RAB9ANPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0830349-A1 METHOD FOR PREPARING N, N'-DISUBSTITUED CYCLIC UREAS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-03-25 EP claimed
WO-1996039393-A1 METHOD FOR PREPARING N, N'-DISUBSTITUED CYCLIC UREAS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-12-12 WO claimed